Live streaming data from August offers a perspective for understanding the shifts in China Star Entertainment's business.
According to the performance report for Xiang Zuo Luxury Goods' debut live stream, total GMV for the single session reached RMB 150 million, maintaining its top position on the overall sales leaderboard. Of this, luxury bags accounted for approximately RMB 110 million in GMV, while luxury watches and jewelry contributed around RMB 40 million. LV items alone generated about RMB 30 million, and Cartier watches approximately RMB 25 million. The session attracted over 7 million viewers and secured more than 20,000 luxury goods orders, ranking first on multiple daily charts including clothing, bags, accessories, and fashion luxury.
Comparing these figures with the listed company's interim results: In the first half of 2026, China Star Entertainment's multimedia and entertainment segment reported revenue of HKD 75.715 million. The GMV from the August debut livestream was roughly twice the total revenue of this segment for the entire first half. This suggests that business growth momentum in the second half has strengthened compared to the interim reporting period.
Notably, there is a connection between Xiang Zuo's live streaming business and the listed company's core operations. According to China Star Entertainment's ESG report, its multimedia and entertainment operations in mainland China are managed by Hangzhou Yingming Xiangtai Media Co., Ltd., covering live commerce, multi-channel operations, and proprietary brand product sales. A traceable commercial link has been established between celebrity IP, live streaming transactions, and the listed company's multimedia segment.
Interim report data: Gross profit margin increased by 41.7 percentage points, with losses narrowing significantly.
On August 28, 2026, China Star Group (00326.HK) issued...
According to the performance report for Xiang Zuo Luxury Goods' debut live stream, total GMV for the single session reached RMB 150 million, maintaining its top position on the overall sales leaderboard. Of this, luxury bags accounted for approximately RMB 110 million in GMV, while luxury watches and jewelry contributed around RMB 40 million. LV items alone generated about RMB 30 million, and Cartier watches approximately RMB 25 million. The session attracted over 7 million viewers and secured more than 20,000 luxury goods orders, ranking first on multiple daily charts including clothing, bags, accessories, and fashion luxury.
Comparing these figures with the listed company's interim results: In the first half of 2026, China Star Entertainment's multimedia and entertainment segment reported revenue of HKD 75.715 million. The GMV from the August debut livestream was roughly twice the total revenue of this segment for the entire first half. This suggests that business growth momentum in the second half has strengthened compared to the interim reporting period.
Notably, there is a connection between Xiang Zuo's live streaming business and the listed company's core operations. According to China Star Entertainment's ESG report, its multimedia and entertainment operations in mainland China are managed by Hangzhou Yingming Xiangtai Media Co., Ltd., covering live commerce, multi-channel operations, and proprietary brand product sales. A traceable commercial link has been established between celebrity IP, live streaming transactions, and the listed company's multimedia segment.
Interim report data: Gross profit margin increased by 41.7 percentage points, with losses narrowing significantly.
On August 28, 2026, China Star Group (00326.HK) issued...
On September 7, 2026, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (02041.HK) was officially listed on the Hong Kong Stock Exchange.
This Shenzhen-headquartered global medical device provider offered 38.9106 million H shares globally, with an offer price of HK$15.42 per share. The Hong Kong public offering portion was oversubscribed by 436.37 times, while the international offering was subscribed 2.35 times. Based on a lot size of 100 shares, the minimum entry cost is approximately HK$1,557.
Mindray's listing brings the total number of new medical device IPOs on the HKEX in 2026 to six. How should investors view this so-called "hidden champion" of the medical device industry post-listing?
As the "15th Five-Year Plan" kicks off, the policy主线 for medical devices becomes increasingly clear
2026 marks the start of the "15th Five-Year Plan," with policy frameworks becoming increasingly clear across R&D, allocation, and demand sides.
From the R&D perspective, the focus is on breakthroughs in core technologies.
On March 24, the National Medical Products Administration launched the three-year "Spring Rain Action" for the transformation of clinical innovation achievements in medical devices, prioritizing innovative medical device projects with the potential to break through key technologies and achieve domestic substitution. On July 13, the State Council issued the "National Health 15th Five-Year Plan." This is the first time a five-year plan has proposed "full-chain support for the development and application of innovative drugs and medical devices," explicitly increasing support for the R&D of key core technologies, components, and complete units for high-end medical devices. Top-level planning sets the direction, review reforms accelerate pace, and policy...
This Shenzhen-headquartered global medical device provider offered 38.9106 million H shares globally, with an offer price of HK$15.42 per share. The Hong Kong public offering portion was oversubscribed by 436.37 times, while the international offering was subscribed 2.35 times. Based on a lot size of 100 shares, the minimum entry cost is approximately HK$1,557.
Mindray's listing brings the total number of new medical device IPOs on the HKEX in 2026 to six. How should investors view this so-called "hidden champion" of the medical device industry post-listing?
As the "15th Five-Year Plan" kicks off, the policy主线 for medical devices becomes increasingly clear
2026 marks the start of the "15th Five-Year Plan," with policy frameworks becoming increasingly clear across R&D, allocation, and demand sides.
From the R&D perspective, the focus is on breakthroughs in core technologies.
On March 24, the National Medical Products Administration launched the three-year "Spring Rain Action" for the transformation of clinical innovation achievements in medical devices, prioritizing innovative medical device projects with the potential to break through key technologies and achieve domestic substitution. On July 13, the State Council issued the "National Health 15th Five-Year Plan." This is the first time a five-year plan has proposed "full-chain support for the development and application of innovative drugs and medical devices," explicitly increasing support for the R&D of key core technologies, components, and complete units for high-end medical devices. Top-level planning sets the direction, review reforms accelerate pace, and policy...
1
Gelong Hui, September 7 | Computing hardware stocks make a comeback: Zhongji Innolight surged over 10%, while Accelink Technologies, Jiangfeng Electronics, Eoptolink, and Xiechuang Data rose more than 8%, driving the underlying index of Tianhong ChiNext ETF (159977) up by over 3.6%. Tianhong ChiNext ETF (159977) tracks the ChiNext Index. As the main battleground for "new quality productive forces," the ChiNext Board covers high-growth new economy sectors such as batteries (CATL), optical communications (Zhongji Innolight/Eoptolink/Tfc Optical Communication), photovoltaic equipment (Sungrow Power Supply), and semiconductors/AI hardware. It serves as a concentrated broad-based index representing new quality productive forces in the A-share market, continuously benefiting from the global wave of AI computing infrastructure build-out and energy transition. Feeder funds: (Class A: 001592, Class C: 001593, Class Y: 022960). On the news front, the industry is seeing multiple tailwinds. 1. Seven ministries and commissions jointly issued a document to strengthen AI infrastructure, with policies explicitly aiming to cultivate over 10,000 AI sci-tech innovation enterprises within three years. 2. Goldman Sachs initiated coverage on Zhongji Innolight's H-shares with a "Buy" rating and a target price of HK$3,267. Goldman Sachs released a research report initiating coverage on Zhongji Innolight's H-shares with a "Buy" rating and a 12-month target price of HK$3,267 (implying 224.8% upside potential); it reaffirmed its "Buy" rating on the A-shares, maintaining a target price of RMB 2,645 (implying 224.9% upside potential). 3. OpenAI released GPT-6 Astra...
Gelonghui, September 7 | In the afternoon, gains in the AI hardware sector widened further, with the CPO sector leading the rally. As of 13:45, the underlying index of China Southern Asset Management's ChiNext Artificial Intelligence ETF (159382) jumped 5.05%. On the news front, the sector benefited from multiple positive catalysts: reports of a CPO equipment shortage, Goldman Sachs doubling the target price for optical module leaders, and breakthroughs in AI intelligence: ① The CPO equipment shortage has ignited a wave of order backlogs from international clients to Taiwan. Media reports indicate that as silicon photonics commercialization accelerates, demand for packaging and testing equipment has exploded. Some key equipment and precision components are in short supply. Hiwin Technologies confirmed that international customers have continuously placed additional orders. The procurement boom has spread from equipment to precision transmission and positioning platforms, prompting related manufacturers to work overtime to meet demand. ② On the morning of September 7, Goldman Sachs released an in-depth report on China's leading optical module companies, initiating coverage on H-shares while reiterating a Buy rating on A-shares, with a target price of RMB 2,645. Based on the report's reference price of RMB 814, this implies a potential upside of 224.9%. ③ Goldman Sachs defined OpenAI's Astra model as "the capability breakthrough AI bulls have been waiting for." The head of Goldman Sachs' Delta One trading desk pointed out that Astra's capabilities significantly lead peers. Compared to simple price cuts, stronger model intelligence is expected to open up new application scenarios, expand the AI demand curve, and drive the industry to continue increasing computing power investment, reigniting the AI capital expenditure cycle. ④ Earnings realization validates prosperity. A-share C...
Recently, Sunshine Insurance (6963.HK) announced its results for the first half of 2026. Here is an infographic to help you understand the specifics. $SUNSHINE INS (06963.HK)$
ExpandGelonghui, September 7 | From August 20 to September 4, Yan Zhi Wu (1497.HK) conducted share buybacks on 12 trading days, spending a cumulative total of approximately HKD 3.7173 million to repurchase 577,600 shares. The average buyback price was approximately HKD 6.44 per share, with the cumulative number of shares repurchased in this round accounting for about 0.13% of the total share capital. The continuous buybacks reflect management's recognition of the company's long-term value and demonstrate confidence in its future development. $YAN PALACE (01497.HK)$
On September 4, Tianxing Medical (01609.HK) was officially included as a constituent of the Stock Connect. For this domestic leader in sports medicine, which has been listed for only a few months, this marks a new turning point from pricing by industrial capital to valuation by the broader market, bringing the company into the view of a wider investor base. $STAR SPORTS MED (01609.HK)$
The core question facing the market is: Does this company, which has broken through against the tide during centralized procurement, seen explosive growth in its overseas business, and rapidly launched its innovative pipeline, possess the growth logic to navigate economic cycles and support a new leap in market capitalization?
The answer lies in four verifiable core anchors, which also serve as the important basis for southbound capital to continue re-evaluating its value in the future.
1. Scarcity Anchor: Leader in a niche segment amid the wave of domestic substitution
China's sports medicine sector is a "long slope with thick snow" track within the medical device industry. The domestic end-market size is expected to exceed RMB 21 billion. According to data from Frost & Sullivan, the more specific market for implants and devices was valued at approximately RMB 5.4 billion in 2024 and is projected to reach RMB 12.1 billion by 2030, representing a compound annual growth rate (CAGR) of 14.3%. Growth drivers include increased sports participation rates and an aging population, resulting in highly certain demand.
However, this track has long been monopolized by multinational giants such as Smith & Nephew and Johnson & Johnson, with imported brands collectively holding 60%-70% of the market share. Four of the top five players in the industry are foreign brands. Only Tianxing Medical has broken this pattern: Based on 2024 sales revenue, the company accounted for 6...
The core question facing the market is: Does this company, which has broken through against the tide during centralized procurement, seen explosive growth in its overseas business, and rapidly launched its innovative pipeline, possess the growth logic to navigate economic cycles and support a new leap in market capitalization?
The answer lies in four verifiable core anchors, which also serve as the important basis for southbound capital to continue re-evaluating its value in the future.
1. Scarcity Anchor: Leader in a niche segment amid the wave of domestic substitution
China's sports medicine sector is a "long slope with thick snow" track within the medical device industry. The domestic end-market size is expected to exceed RMB 21 billion. According to data from Frost & Sullivan, the more specific market for implants and devices was valued at approximately RMB 5.4 billion in 2024 and is projected to reach RMB 12.1 billion by 2030, representing a compound annual growth rate (CAGR) of 14.3%. Growth drivers include increased sports participation rates and an aging population, resulting in highly certain demand.
However, this track has long been monopolized by multinational giants such as Smith & Nephew and Johnson & Johnson, with imported brands collectively holding 60%-70% of the market share. Four of the top five players in the industry are foreign brands. Only Tianxing Medical has broken this pattern: Based on 2024 sales revenue, the company accounted for 6...
On September 7, the latest round of adjustments to the Stock Connect officially took effect, with Lightelligence, which listed on the Hong Kong Stock Exchange in April this year, approved for inclusion.
Inclusion in the Stock Connect does not change a company's fundamentals, but it does alter a critical dynamic: which capital flows can invest in it and which institutions are willing to conduct long-term research on it.
For the capital markets, the special significance of Stock Connect inclusion lies in bringing an asset that is extremely scarce in both the A-share and Hong Kong stock markets before southbound capital—namely, a provider of all-optical, system-level computing power solutions. $XIZHI TECH-P (01879.HK)$
I. Stock Connect Inclusion Brings Threefold Incremental Capital Market Benefits
First is the improvement in liquidity.
Liquidity in the Hong Kong stock market is highly fragmented. Some newly listed technology companies, despite possessing unique technologies and industrial positioning, may suffer from a liquidity discount due to limited participating capital and insufficient trading activity.
The performance of MiniMax provides an intuitive case study. After being included in the Stock Connect on August 6, MiniMax quickly attracted attention from southbound capital. In August 2026, mainland investors purchased approximately HK$10.6 billion worth of MiniMax shares through the Stock Connect, exceeding the purchase amounts for Alibaba and Tencent during the same period. Since its inclusion, MiniMax's share price has cumulatively risen by over 50%.
Stock Connect inclusion brings Lightelligence more than just an additional trading channel; it also offers the potential for an improved liquidity discount and the rediscovery of its market value.
Next is the shift in investor structure.
Domestic public funds, private equity, insurance companies, and others...
Inclusion in the Stock Connect does not change a company's fundamentals, but it does alter a critical dynamic: which capital flows can invest in it and which institutions are willing to conduct long-term research on it.
For the capital markets, the special significance of Stock Connect inclusion lies in bringing an asset that is extremely scarce in both the A-share and Hong Kong stock markets before southbound capital—namely, a provider of all-optical, system-level computing power solutions. $XIZHI TECH-P (01879.HK)$
I. Stock Connect Inclusion Brings Threefold Incremental Capital Market Benefits
First is the improvement in liquidity.
Liquidity in the Hong Kong stock market is highly fragmented. Some newly listed technology companies, despite possessing unique technologies and industrial positioning, may suffer from a liquidity discount due to limited participating capital and insufficient trading activity.
The performance of MiniMax provides an intuitive case study. After being included in the Stock Connect on August 6, MiniMax quickly attracted attention from southbound capital. In August 2026, mainland investors purchased approximately HK$10.6 billion worth of MiniMax shares through the Stock Connect, exceeding the purchase amounts for Alibaba and Tencent during the same period. Since its inclusion, MiniMax's share price has cumulatively risen by over 50%.
Stock Connect inclusion brings Lightelligence more than just an additional trading channel; it also offers the potential for an improved liquidity discount and the rediscovery of its market value.
Next is the shift in investor structure.
Domestic public funds, private equity, insurance companies, and others...
1
Gelonghui, September 7 | On September 7, the ChiNext Computing Power ETF (158063) under China Southern Asset Management officially opened for public offering. It is one of the first batch of ETFs approved to track the ChiNext Computing Power Infrastructure Index (970083). The index carefully selects 50 sample stocks from the ChiNext board whose businesses cover computing, networking, storage, and operations & maintenance. It spans across computing hardware, data centers, and operational segments such as computing power leasing. Individual constituent weightings are capped, with the top ten constituents accounting for approximately 44% in total. The index components are primarily small- and mid-cap stocks, highlighting significant growth elasticity. The index has demonstrated impressive long-term performance: since its base date (December 30, 2022), it has cumulatively risen by 378.81%. Annual returns for 2023 to 2025 were 48.46%, 34.97%, and 79.34%, respectively, with a further increase of 33.25% since 2026. The computing power sector is driven by both demand and policy. On the demand side, McKinsey estimates that global AI inference computing power demand will rise from 20.9 GW in 2025 to 56.3 GW in 2028, surpassing training demand (46.1 GW) for the first time. On the policy side, the spatial layout of the national integrated computing power network "8+10+3" continues to advance, with direct investment in the computing network expected to reach the trillion-yuan level. By 2025, the scale of China's artificial intelligence industry had exceeded RMB 1.2 trillion (CAICT). ChiNext Computing Power ETF (1580...
On September 4, the Stock Connect program entered a new periodic adjustment window. A batch of high-potential stocks will officially come into view of mainland investors and begin trading on September 7. Among them, Haiqing Zhiyuan (01392.HK), dubbed the "first Physical AI stock" after its June listing, has recently become the primary focus of southbound capital.
As one of the few multispectral Physical AI companies in the Hong Kong market to have successfully achieved commercial implementation, the company just released its impressive first semi-annual results since listing. Coupled with the consecutive acquisition of multiple official industry qualifications, it stands at the intersection of improved liquidity and industrial growth.
1. Stock Connect Adjustment Window: Limited Event-Driven Upside; Operational Fundamentals Remain the Core Anchor
After the close on September 4, the Shanghai Stock Exchange issued a notice stating that, in accordance with the relevant provisions of the Implementation Measures for Shanghai-Hong Kong Stock Connect Business, Haiqing Zhiyuan (01392.HK) has been formally added to the list of eligible securities for Stock Connect. This adjustment will take effect from Monday, September 7. This means mainland investors can now directly buy and sell shares through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, effectively unlocking access for southbound capital to Haiqing Zhiyuan.
After years of development, southbound capital has become a non-negligible pricing force in the Hong Kong stock market. The "expectation of inclusion" has also spawned speculative trading behaviors focused solely on index inclusion—some companies rely merely on having a market capitalization close to the threshold, lacking substantive business output, and thus struggle to find long-term support after short-term price volatility. However, Haiqing Zhiyuan is certainly not such a target: from 2023 to 2025, its revenue jumped from RMB 117 million...
As one of the few multispectral Physical AI companies in the Hong Kong market to have successfully achieved commercial implementation, the company just released its impressive first semi-annual results since listing. Coupled with the consecutive acquisition of multiple official industry qualifications, it stands at the intersection of improved liquidity and industrial growth.
1. Stock Connect Adjustment Window: Limited Event-Driven Upside; Operational Fundamentals Remain the Core Anchor
After the close on September 4, the Shanghai Stock Exchange issued a notice stating that, in accordance with the relevant provisions of the Implementation Measures for Shanghai-Hong Kong Stock Connect Business, Haiqing Zhiyuan (01392.HK) has been formally added to the list of eligible securities for Stock Connect. This adjustment will take effect from Monday, September 7. This means mainland investors can now directly buy and sell shares through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, effectively unlocking access for southbound capital to Haiqing Zhiyuan.
After years of development, southbound capital has become a non-negligible pricing force in the Hong Kong stock market. The "expectation of inclusion" has also spawned speculative trading behaviors focused solely on index inclusion—some companies rely merely on having a market capitalization close to the threshold, lacking substantive business output, and thus struggle to find long-term support after short-term price volatility. However, Haiqing Zhiyuan is certainly not such a target: from 2023 to 2025, its revenue jumped from RMB 117 million...
+3
2
![[empty]](https://cdn.futustatic.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://cdn.futustatic.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)